References

• 1979A New Depression Scale Designed to be Sensitive to Change13,964 cited
• 1994Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States12,377 cited
• 1976ECDEU Assessment Manual for Psychopharmacology8,899 cited
• 1996Agoraphobia, Simple Phobia, and Social Phobia in the National Comorbidity Survey996 cited
• 2008World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision860 cited
• 1998Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.460 cited
• 1998Social Phobia Subtypes in the National Comorbidity Survey398 cited
• 1999Disability and quality of life in pure and comorbid social phobia – Findings from a controlled study326 cited
• 1995Sertraline for social phobia: a double-blind, placebo-controlled crossover study239 cited
• 1996Social Phobia in General Health Care: An Unrecognised Undertreated Disabling Disorder219 cited
• 2004Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study175 cited
• 2004Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: Randomised, double-blind, placebo-controlled, fixed-dose study164 cited
• 2003Escitalopram in the Treatment of Panic Disorder